Adjuvant chemotherapy in patients with completely resected small cell lung cancer: A retrospective analysis of 26 consecutive cases

Hidenori Mizugaki, Yutaka Fujiwara, Noboru Yamamoto, Shigehiro Yagishita, Satoru Kitazono, Ayako Tanaka, Hidehito Horinouchi, Shintaro Kanda, Hiroshi Nokihara, Koji Tsuta, Hisao Asamura, Tomohide Tamura

研究成果: Article査読

抄録

Objective: Several clinical studies have demonstrated the efficacy and safety of adjuvant chemotherapy in patients with completely resected small cell lung cancer for a selected limited stage. However, it is unclear whether adjuvant chemotherapy is feasible in clinical practice. The objective of this study was to analyze the efficacy and safety of adjuvant chemotherapy for small cell lung cancer patients retrospectively in clinical practice. Methods: From January 2002 to March 2012, 56 small cell lung cancer patients underwent surgery as initial therapy in our institute. Of these, 26 patients received adjuvant chemotherapy. The clinical data of patients who received adjuvant chemotherapy were retrospectively analyzed. Results: The chemotherapy regimens were cisplatin and irinotecan in 16 patients, cisplatin and etoposide in 1 and carboplatin and etoposide in 9. Median follow-up time was 44.8 months. Nineteen (73%) patients received the full course of chemotherapy. Median recurrence-free survival was 21.4 months. Median survival time was not reached. There was no treatment-related death. Conclusion: Adjuvant chemotherapy may be generally safe and efficacious in selected small cell lung cancer patients.

本文言語English
ページ(範囲)835-840
ページ数6
ジャーナルJapanese journal of clinical oncology
44
9
DOI
出版ステータスPublished - 2014 9
外部発表はい

ASJC Scopus subject areas

  • 腫瘍学
  • 放射線学、核医学およびイメージング
  • 癌研究

フィンガープリント

「Adjuvant chemotherapy in patients with completely resected small cell lung cancer: A retrospective analysis of 26 consecutive cases」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル